Target intelligence / Profile preview

TEA domain transcription factor 1, 2, 3, and 4 (TEAD (TEAD1, TEAD2, TEAD3, TEAD4))

Target
TEAD (TEAD1, TEAD2, TEAD3, TEAD4)
Molecular classification
Transcription factor, Hippo pathway effector, DNA-binding protein
01

Overview

TEAD1-4 are a family of highly conserved **transcription factors** characterized by a TEA (TEAD) DNA-binding domain and a coactivator-binding domain. They act as the main terminal effectors in the Hippo signaling pathway, orchestrating key cellular events such as cell proliferation, differentiation, organ size regulation, and stem cell biology in both physiological and pathological settings. TEAD proteins exert their function by binding DNA and recruiting transcriptional co-activators—including YAP and TAZ—to control the expression of genes that drive cell growth and survival. Abnormal TEAD activity is closely associated with tumorigenesis, including EMT, metastasis, and chemoresistance, making these proteins promising therapeutic targets under active investigation.

Other names
TEADsTEA/ATTS domain familyTEA/TEAD transcription factors
02

Mechanism of action

Inhibition of TEAD-YAP/TAZ binding Blockade of transcriptional activation of growth-promoting genes Targeted protein degradation (e.g., via ubiquitination pathways)

03

Biological functions

Regulation of cell proliferationCell survivalTissue regenerationStem cell maintenanceCellular differentiationOrgan size controlGene expression regulation
04

Disease associations

Cancer (e.g., roles in epithelial–mesenchymal transition, metastasis, and drug resistance)FibrosisDevelopmental disorders (affecting organ and tissue development)
05

Safety considerations

On-target effects may disrupt normal tissue regeneration and stem cell functionPotential for off-target effects due to the essential role of TEADs in stem cell renewal and organ development
06

Interacting drugs

Several experimental small molecules and peptides that disrupt TEAD-YAP/TAZ interactions, currently in preclinical or early clinical testing as anti-cancer agents. Specific marketed drugs are not well established yet, but research is active.
07

Biomarkers

TEAD4 protein levels (e.g., as a prognostic marker in cancer)YAP/TAZ nuclear localization (indirect biomarker for TEAD activity)

Beyond the preview

Go deeper on TEA domain transcription factor 1, 2, 3, and 4 (TEAD (TEAD1, TEAD2, TEAD3, TEAD4)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TEA domain transcription factor 1, 2, 3, and 4 (TEAD (TEAD1, TEAD2, TEAD3, TEAD4)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call